Beloved Johnson & Johnson Shares Are Too Expensive [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
|HealthcareBeloved Johnson & Johnson Shares Are Too ExpensiveApr. 29, 2020 12:44 PM ETAbout:Johnson & Johnson (JNJ)by: Mark RoussinHigh Yield Landlord Become a “Passive Landlord” with our 8% Yielding Portfolio.SummaryThough I love the company, JNJ trading at a 17.4x earnings multiple despite earnings guidance for the year cut 15%.JNJ shares have rebounded sharply of their March lows to the tune of 40%.The Medical Device segment, which accounts for 29% of sales, was impacted in Q1 and is expected to be heavily impacted in Q2 as well.On February 6, 2020, JNJ hit an all-time high of $154.50, right before the COVID-19 pandemic began to fully impact the US economy, as much of the focus was still on the breakout in China. However, over the next six weeks, as the breakout began to penetrate the US on a larger scale, the S&P 500 fell 36% while shares ofJNJ dropped roughly 30%Since hitting a low of $109 in late March, shares ofJNJ have rebounded sharply, to the tu
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Catalyst Watch: Intel earnings, drama in Davos, and the fight for Warner Bros. [Seeking Alpha]Seeking Alpha
- Why ORIC Pharmaceuticals (ORIC) Is Up 36.3% After New Cancer Data And Analyst Buzz [Yahoo! Finance]Yahoo! Finance
- Big pharma and investors re-engage in CGTs and race to scale [Yahoo! Finance]Yahoo! Finance
- 2 Rock-Solid Dividend Stocks to Buy for Steady Passive Income [Yahoo! Finance]Yahoo! Finance
- TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website